Accelerating drug development in breast cancer: New frontiers for ER inhibition is a research paper published in Cancer Treatment Reviews (2022). On theSindex it has a DataRank of 0. It has been cited 52 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
MSKCC
Grant: P30 CA008748
National Institutes of Health
National Cancer Institute
American-Italian Cancer Foundation
MeSH Terms
Keywords
Additional file 1 of Breast-conserving surgery is an appropriate procedure for centrally located breast cancer: a population-based retrospective cohort study
Additional file 1 of Breast-conserving surgery is an appropriate procedure for centrally located breast cancer: a population-based retrospective cohort study